摘要
目的观察还原型谷胱甘肽（ＴＡＤ）对病毒性肝炎的疗效。方法治疗组４６例，其中慢性肝炎２５例，给以ＴＡＤ６００ｍｇ，加入１０％葡萄糖液５００ｍｌ中，静脉滴入，１次／ｄ。对照组４６例，共中慢性肝炎２５例，给以门冬氨酸钾镁１ｇ，加入１０％葡萄糖液５００ｍｌ中，静脉滴入，１次／ｄ。共２个月。结果治疗组慢性肝炎有效率为８０．０％；急性肝炎２１例，有效率为８５．７％，急慢性肝炎总有效率为８２．６％。对照组慢性肝炎有效率为６０．０％；急性肝炎２１例，有效率为６６．７％，急慢性肝炎总有效率为６３．０％。两组差异显著（Ｐ＜０．０５）。
AIMS To observe the effect of reduced glutathione(TAD) on viral hepatitis. METHODS Fourty_six patients with acute or chronic viral hepatitis were treated with TAD(600mg in 10% glucose solution) infusion every day for 2 months, and other 46 patients with acute or chronic hepatitis were treated with potassium_magnesium aspartate (1g in 10% glucose solution) infusion every day for 2 months as controls. RESULTS The total effective rates in TAD and control group were 80% and 63% respectively, with statistically significant difference(P<0.05). CONCLUSIONS TAD has excellent response rate in the treatment of patients with acute and chronic viral hepatitis.
关键词
谷胱甘肽
药物疗法
病毒性肝炎
glutathion/therapeutic use hepatitis, viral, human/drug therapy superinfection/drug therapy
